MARKET

PAVM

PAVM

PAVmed
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.820
-0.100
-5.21%
Closed 16:22 04/03 EDT
OPEN
1.880
PREV CLOSE
1.920
HIGH
1.930
LOW
1.730
VOLUME
441.39K
TURNOVER
--
52 WEEK HIGH
3.450
52 WEEK LOW
0.8100
MARKET CAP
66.90M
P/E (TTM)
-2.9078
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average PAVM stock price target is 3.000 with a high estimate of 3.000 and a low estimate of 3.000.

EPS

PAVM News

More
  • The Week Ahead In Biotech: Spotlight On Q1 Pre-Announcements As COVID-19 Continues To Disrupt Operations
  • Benzinga · 15h ago
  • PAVmed Subsidiary Lucid Diagnostics EsoCheck Esophageal Cell Collection Device Receives Prestigious Edison Best New Product Award
  • GlobeNewswire · 3d ago
  • PAVmed Receives $6.3 Million in Gross Proceeds from Completion of November 2019 Financing
  • GlobeNewswire · 5d ago
  • PAVmed to Hold Business Update Conference Call on April 9, 2020
  • GlobeNewswire · 03/24 14:30

Industry

Advanced Medical Equipment & Technology
-1.50%
Healthcare Equipment & Supplies
-1.17%

Hot Stocks

Symbol
Price
%Change

About PAVM

PAVmed Inc. is a medical device company organized to conceive, develop and commercialize a diversified pipeline of products. The Company's products include PortIO, Caldus, CarpX, NextCath, DisappEAR and NextFlo. PortIO is an implantable vascular access device, which does not require accessing the central venous system and does not have an indwelling intravascular component. CarpX is a percutaneous device to treat carpal tunnel syndrome. NextCath is a self-anchoring catheter, which does not require suturing, traditional anchoring techniques or add-on catheter securement devices. The Company's DisappEAR is an Antibiotic-eluting Resorbable Ear Tubes. The Company is engaged in developing and commercializing antibiotic-eluting resorbable ear tubes based on an aqueous silk technology conceived and developed at these institutions. The Company is engaged in developing disposable infusion system with variable flow resistors. Caldus is a disposable tissue ablation device.
More

Webull offers kinds of PAVmed Inc stock information, including NASDAQ:PAVM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PAVM stock news, and many more online research tools to help you make informed decisions.